At this event, One Nucleus asks, "If you knew now what you will know in 2030, would you design the same R&D space and choose the same location?"
Sue Foxley, Research Director at Bidwells, will present on the current and future real estate requirements in the Life Science sector given emerging scientific and technological advances. This will be considered in the context of the current market provision and challenges for companies seeking business space to operate and grow.
Sue's short presentation will be followed by a panel discussing what factors will play a role in shaping the 2030 vision of Life Science ecosystems, including the role that real estate developers will play in determining the space that companies might choose.
Programme:
17.30 - Arrival and registration
17.45 - Presentation: Life Sciences 2030 Sue Foxley, Research Director, Bidwells
18.00 - Panel Discussion: What Factors are Shaping the 2030 Life Science Future? Sue Foxley, Research Director, Bidwells (Moderator)
Roz Bird, CEO, Anglia Innovation Partnership LLP, Norwich Research Park
Douglass Cuff, Vice President of U.K. Real Estate, IQHQ
Michael Chen, Co-Founder and CEO, Nuclera
Robert Tansley, Partner, Cambridge Innovation Capital plc
19.00 - Networking and Refreshments
20.00 - Close
Hybrid Meeting Format
In-person at Bidwells (Cambridge) and streamed via Teams. Register now and One Nucleus will be in touch post registration to confirm your preference for attendance.
Copyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.